EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line
- 1 September 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (9) , 2768-2778
- https://doi.org/10.1158/1535-7163.mct-07-2263
Abstract
The Eph receptor tyrosine kinases and their ephrin ligands form a unique cell-cell contact-mediated bidirectional signaling mechanism for regulating cell localization and organization. High expression of Eph receptors in a wide variety of human tumors indicates some roles in tumor progression, which makes these proteins potential targets for anticancer therapy. For this purpose, we did gene expression profiling for 47 surgical specimens of brain tumors including 32 high-grade glioma using a microarray technique. The analysis, focused on the receptor tyrosine kinases, showed that EphA4 mRNA in the tumors was 4-fold higher than in normal brain tissue. To investigate the biological significance of EphA4 overexpression in these tumors, we analyzed EphA4-induced phenotypic changes and the signaling mechanisms using human glioma U251 cells. EphA4 promoted fibroblast growth factor 2-mediated cell proliferation and migration accompanied with enhancement of fibroblast growth factor 2-triggered mitogen-activated protein kinase and Akt phosphorylation. In addition, active forms of Rac1 and Cdc42 increased in the EphA4-overexpressing cells. Furthermore, we found that EphA4 formed a heteroreceptor complex with fibroblast growth factor receptor 1 (FGFR1) in the cells and that the EphA4-FGFR1 complex potentiated FGFR-mediated downstream signaling. Thus, our results indicate that EphA4 plays an important role in malignant phenotypes of glioblastoma by enhancing cell proliferation and migration through accelerating a canonical FGFR signaling pathway. [Mol Cancer Ther 2008;7(9):2768–78]Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Identification of expressed genes characterizing long-term survival in malignant glioma patientsOncogene, 2006
- Eph receptor signalling casts a wide net on cell behaviourNature Reviews Molecular Cell Biology, 2005
- New targeted treatments in lung cancer — overview of clinical trialsLung Cancer, 2004
- The RhoGEF Pebble is required for cell shape changes during cell migration triggered by theDrosophilaFGF receptor HeartlessDevelopment, 2004
- Eph–ephrin promiscuity is now crystal clearNature Neuroscience, 2004
- Rho GTPases in cell biologyNature, 2002
- EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cellsThe FASEB Journal, 2002
- Expression of Eph Receptors in Skeletal Muscle and Their Localization at the Neuromuscular JunctionMolecular and Cellular Neuroscience, 2001
- Nuk Controls Pathfinding of Commissural Axons in the Mammalian Central Nervous SystemCell, 1996
- Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomasJournal of Neuro-Oncology, 1994